CRP and temporal arteritis: This suggests that statins may be valuable in decreasing CRP levels in inflammatory diseases like GCA and can potentially play a role in preventing some of the cardiovascular events observed in these patients, especially when steroids and other anti-inflammatory medications are tapered off due to clinical remission.